In the specialized field of immunology and neuroscience research, the study of Myelin Oligodendrocyte Glycoprotein (MOG) remains a cornerstone for understanding central nervous system (CNS) dynamics. As an enthusiast who follows the latest developments in peptide synthesis a 03-Jan-2024—Myelin oligodendrocyte glycoprotein antibody-associated disease, also known as MOGAD, is a rare inflammatory disease that affects the central nervous system.Read more nd laboratory applications, I have observed a growing interest in the specific utility of 3 MOG peptides and their variants in experimental models.
Defining the Entity: MOG and its Peptide Fragments
Myelin oligodendrocyte glycoprotein (MOG) is MOG 35-55 peptideis an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in Read more a critical membrane protein found exclusively Myelin Oligodendrocyte Glycoprotein (MOG) (35-55) (human) within the CNS, localized on the surface of myelin sheaths and oligodendrocyte cytoplasmic membranes. From a technical standpoint, the MOG p Myelin Oligodendrocyte Glycoprotein (MOG) (35-55) (human) rotein is a single, non-glycosylated polypeptide chain. When researchers discuss MOG peptide fragments, they are typically referring to specific immunodominant epitopes used to stimulate antigen-specific T cell responses.
The most frequently studied fragment is the MOG Protein 35-55. This sequence is widely recognized as a key peptide for inducing experimental autoimmune encephalomyelitis (EAE) in rodent models. By utilizing high-purity MOG 35-55 peptide, labs can reliably create controlled environments to observe immunological pathways.
Key Variations and Structural Significance
When sourcing these compounds, one often encounters MOG 35-55 human sequences (MEVGWYRPPFSRVVHLYRNGK) and their murine counterparts. The differentiation between these is vital for experimental accuracy. Furthermore, researchers are now exploring single β3-amino acid substitutions to MOG peptides to investigate how structural modifications alter binding affinities and immunogenicity.
I have tracked several developments regarding OM-MOG35–55, which highlights the shift toward personalized antigen research. Whether you are looking to explore high-purity MOG 35–55 peptide for T cell assays or seeking a standardized high-purity MOG (35-55) peptide for academic inquiry, the quality of the synthesis—often verified by a molecular mass of approximately 2582 Dalton—is paramount.
Distinguishing Research Models from Clinical Contexts
It is essential to distinguish between the use of these peptides in a laboratory setting and clinical terminology. While the term MOG antibody disease (MOGAD) or myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) appears frequently in literature regarding inflammatory demyelinating conditions, these are clinical diagnostic categories.
From a research perspective, Myelin oligodendrocyte glycoprotein (MOG) peptide (35-55) is strictly a tool for scientific modeling. When we discuss 3 MOG fragments or specific analogs, we are analyzing the biochemical interactions of these sequences as antigens, not providing guidance for human health. The focus remains on the structural biology of the Myelin Oligodendrocyte Glycoprotein and its role in basic cellular research.
Why Quality Matters in Peptide Research
For those involved in procurement for research facilities, the integrity of the MO Myelin oligodendrocyte glycoprotein MOG (35-55) is widely used in models of neuronal injury induced by MPTP and models of multiple sclerosis. G peptide is non-negotiable. Whether you are ordering a standard MOG 35-55 or a specialized variant, ensure the supplier provides documentation on purity levels and sequence verification.
The study of Myelin ol computational evidence of demyelination-related epitopes igodendrocyte glycoprotein (MOG) continues to evolve. By focusing on the precise application of these specific peptide chains, the scientific community gains deeper insights into the complex architecture of the CNS. Always prioritize suppliers who demonstrate transparency regarding the synthesis of MOG 35- Myelin Oligodendrocyte Glycoprotein Peptide (35-55) 55 human and other related Myelin oligodendrocyte glycoprotein MOG (35-55) fragments to ensure your experimental data remains robust and reproducible.